A detailed history of Mml Investors Services, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 29,673 shares of VKTX stock, worth $840,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,673
Previous 20,352 45.8%
Holding current value
$840,339
Previous $1.29 Million 7.3%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$38.28 - $78.03 $356,807 - $727,317
9,321 Added 45.8%
29,673 $1.19 Million
Q3 2024

Nov 15, 2024

BUY
$49.84 - $70.47 $668,304 - $944,932
13,409 Added 193.13%
20,352 $1.29 Million
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $58,621 - $99,207
1,237 Added 21.68%
6,943 $368,000
Q1 2024

May 14, 2024

BUY
$17.4 - $94.5 $99,284 - $539,217
5,706 New
5,706 $468,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $2.17B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.